placebo PH20 SC PFS, Vyvgart 1 000 mg solution for injection in pre-filled syringe
ARGX-113-2317
Phase 2 small_molecule active
Quick answer
placebo PH20 SC PFS, Vyvgart 1 000 mg solution for injection in pre-filled syringe for Systemic Sclerosis is a Phase 2 program (small_molecule) at Argenx with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Argenx
- Indication
- Systemic Sclerosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active